title: Reply to letter to the editor: Re: Comparison of COX-2, Ki-67, and BCL-2 expression in normal esophageal mucosa, Barrett's esophagus, dysplasia, and adenocarcinoma with postablation mucosa and implications for ablative therapies (Online First).
authors.forename: Sri Ganeshamurthy
authors.initials: SG
authors.lastname: Thrumurthy
authors.forename: Christopher John
authors.initials: CJ
authors.lastname: Lewis
authors.forename: Susan
authors.initials: S
authors.lastname: Pritchard
authors.forename: Gordon
authors.initials: G
authors.lastname: Armstrong
authors.forename: Stephen Edwin Arthur
authors.initials: SE
authors.lastname: Attwood
mesh_terms: D000230:Adenocarcinoma / Q000378:metabolism*; D001471:Barrett Esophagus / Q000378:metabolism*; D051546:Cyclooxygenase 2 / Q000096:biosynthesis*; D004938:Esophageal Neoplasms / Q000378:metabolism*; D004947:Esophagus / Q000378:metabolism*; D006801:Humans; D019394:Ki-67 Antigen / Q000096:biosynthesis*; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000096:biosynthesis*
chemical_list: D019394:Ki-67 Antigen; D019253:Proto-Oncogene Proteins c-bcl-2; D051546:Cyclooxygenase 2